Clearance Summary
EMBA Hourglass Peripheral Embolization Device (PED) received FDA 510(k) clearance under submission number K200083, sponsored by Embolic Acceleration, LLC. The device was reviewed via the Special premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2020-02-14.
- Submission: K200083
- Applicant / Sponsor: Embolic Acceleration, LLC
- Clearance pathway: Special
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.3300
- Decision date: 2020-02-14
Classification & Regulation
This clearance is catalogued under FDA product code KRD and 21 CFR 870.3300, within the Cardiovascular review panel as a Class II device.